120
Participants
Start Date
October 7, 2021
Primary Completion Date
June 1, 2026
Study Completion Date
June 1, 2028
Paxman Scalp Cooling System
Cap attached to coolant lines connected to a refrigeration unit placed on scalp
Eribulin
Intravenous Infusion
Sacituzumab govitecan
Intravenous Infusion
Trastuzumab deruxtecan
Intravenous Infusion
RECRUITING
Brigham and Women's Hospital, Boston
RECRUITING
Dana Farber Cancer Institute, Boston
Collaborators (3)
Paxman Coolers Limited
UNKNOWN
AstraZeneca
INDUSTRY
Eisai Inc.
INDUSTRY
Daiichi Sankyo
INDUSTRY
Gilead Sciences
INDUSTRY
Dana-Farber Cancer Institute
OTHER